ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Expedite Drug Development With An Integrated CDMO-CRO Model

  From optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.

• Addressing The Specific Complexities Of Oncology eCOA Clinical Trials

  What are the specific tools and keys to conduct eCOA trials in oncology successfully? This article identifies some of the relevant solutions to tackle oncology protocol complexities.

• With The Emergence Of DCTs, Do We Really Need A CTMS?

  As decentralized trial designs continue to grow in popularity, do sponsors and CROs really need a clinical trial management system? Explore whether CTMS is necessary with the emergence of DCTs.

• Building A Clinical Research AI Governance Framework

  Learn how structured oversight, transparency, and collaboration help ensure compliance, reduce bias, and build trust while enabling innovation in increasingly data-driven trials.

• Measuring The True Patient Experience

  Utilizing the insights covered in this article can inform the design and implementation of cancer trials, ultimately contributing to improved patient care and treatment outcomes.

• From Months To Hours: MMC Medical's EDC Revolution

  Learn how a specialized CRO reduced study build times by 95%. Discover strategies for template reusability and flexible resource scaling to accelerate early-stage medical device validation.

• The Right EDC Solution For Oncology Trials

  Oncology clinical trials can be very complex, as are their data management needs. Understand why selecting the right EDC is crucial for managing them efficiently while providing compassionate care.

• Planning For Complex Change At Your Organization

  With technology advancing clinical operations, proactive adaptation is paramount for organizations to remain at the forefront. How can your organization effectively navigate these evolving dynamics?

• The Regulatory Governance Gap In Clinical Trial AI

  Regulators are no longer questioning whether AI belongs in clinical trials; however, they’re demanding a governed infrastructure that makes every AI-driven decision auditable and defensible.

• Oncology Preferences From Patients And Caregivers On Trial Tech

  Delve into the preferences of patients and caregivers in the field of oncology, specifically regarding eConsent, telehealth, wearables, and other digital technologies.